Dentsply Sirona (NASDAQ:XRAY) announced on Tuesday that it plans to refocus its Byte business model to emphasize treatments ...
On Oct. 24, no-moat Dentsply Sirona unexpectedly announced that it has voluntarily suspended the sale and marketing of Byte aligners and impression kits after consulting with the Food and Drug ...
DENTSPLY SIRONA (XRAY) announced that the company plans to refocus the Byte business model around treatments that include expanded in-person dentist oversight. The Company is evaluating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results